Emerging in the arena of excess body fat management, retatrutide presents a different method. Different from many available medications, retatrutide operates as a double agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) receptors. This dual engagement promotes various helpful effect